Low-Dose Sirolimus for the Treatment of RUNX1 Familial Platelet Disorder
Low-Dose Sirolimus for the Treatment of RUNX1 Familial Platelet Disorder
Recruiting · NCT07844694 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Low-Dose Sirolimus for the Treatment of RUNX1 Familial Platelet Disorder | hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | Recruiting | Early phase 1 | 2026-09-28 | NCT07844694 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| M.D. Anderson Cancer Center | 1145 |
| National Cancer Institute (NCI) | 3015 |
| OHSU Knight Cancer Institute | 61 |
| Oregon Health and Science University | 244 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| OHSU Knight Cancer Institute | Portland | United States | 69 |